Health
Rona Therapeutics Announces IND Filing of RN3161, a Highly Potent and Durable INHBE siRNA for Obesity
SHANGHAI and SANTA BARBARA, Calif., Sept. 15, 2025 /PRNewswire/ -- Rona Therapeutics, a global leader in developing next-generation RNAi therapeutics, announced today the successful submission of RN3161 to the Australian Human Research Ethics Committee (HREC).RN3161 is a proprietary GalNAc-conjug...
FutureCeuticals Files Lawsuit Against NeuroRush Owner for Patent Infringement over Alleged Copycat Ingredient
MOMENCE, Ill., Sept. 15, 2025 /PRNewswire/ -- VDF FutureCeuticals, Inc. filed a lawsuit against Aura Scientific, asserting that its brain performance ingredient NeuroRush – an extract of whole coffee fruit – infringes multiple of FutureCeuticals' patents covering technology relating to coffee fru...
Biostar Pharma Successively Achieved First Patient Dosing for Two Phase II/III Multiregional Clinical Trials of Utidelone Capsule (UTD2)
SAN FRANCISCO, Sept. 15, 2025 /PRNewswire/ -- Biostar Pharma, Inc., the US subsidiary of Beijing Biostar Pharmaceuticals Co., Ltd. ("Biostar", Stock Code: 2563.HK) which is a synthetic biology driven biopharma company focusing on the discovery, development and commercialization of innovative onco...
Medit Link Express for iPad Debuts as Medit i900 Mobility Goes into Shipping
SEOUL, South Korea, Sept. 15, 2025 /PRNewswire/ -- Medit (www.medit.com
Sunsred Launches FDA-cleared Red Light Therapy Devices for Wellness Brands Worldwide
SHENZHEN, China, Sept. 15, 2025 /PRNewswire/ -- Shenzhen Sunsred Technology Co., Ltd. is shaking things up in the wellness tech world with its latest lineup of red light therapy devices. As a go-toOEM/ODM red light therapy manufacturer in this space, Sunsred is meeting the huge global demand for ...
Clinically Proven Human Milk Probiotic LC40® supports Infant Health and Breastfeeding Mothers
SINGAPORE, Sept. 15, 2025 /PRNewswire/ -- Supported by six clinical studies and
two safety trials,Kerry
Akeso Announces First Patient Dose in Global Registrational Trial of Cadonilimab (PD-1/CTLA-4) for PD-1 Treatment-Resistant Hepatocellular Carcinoma
HONG KONG, Sept. 15, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that the first patient has been dosed in its global, multicenter, randomized Phase II registrational trial (COMPASSION-36/AK104-225). The trial will evaluate cadonilimab, Akeso's first-in-class P...
Jointly discovered KAT6i molecule originating from Australian research has initiated Phase 3 in HR+ HER2- Breast Cancer with Pfizer Inc
Australian scientists who discovered how to "turn off" genes that make cancer cells grow are celebrating the next phase of development – with Pfizer's first in class KAT6 inhibitor PF-07248144 now moving to the next stages of clinical investigation. MELBOURNE, Australia, Sept. 15, 2025 /PRNewswi...
New Data, iCARE Study: Hailie® Smartinhaler® Powers Unprecedented Medication Adherence in Patients with COPD and Asthma
Highlights: * Up to 235% increase in real-world adherence compared to published norms (20–40%), across ~850 chronic obstructive pulmonary disease (COPD) and asthma patients. * >60% patients achieved an average two-week baseline adherence with ~4 in 10 patients reaching the critical threshold...
MGI Tech Introduces DNBSEQ-T7+: A Next-Generation 'Data Mining Machine' for Genomics
SHENZHEN, China, Sept. 15, 2025 /PRNewswire/ -- MGI Tech Co., Ltd. (MGI), a company dedicated to developing core tools and technologies that drive innovation in life sciences, announced the launch of the DNBSEQ-T7+, its latest high-throughput sequencer. Designed to meet the rising demand for larg...
Phrontline Biopharma Announces First Patient Dosed in Phase 1 Clinical Trial of TJ101
SHANGHAI and SUZHOU, China, Sept. 14, 2025 /PRNewswire/ -- Phrontline Biopharma , a clinical-stage biotechnology company advancing a new generation of Antibody-Drug Conjugates (ADCs), today announced that the first patient has been successfully dosed in its Phase 1 clinical trial of TJ101, the com...
Lion TCR Achieves Triple FDA Milestones with IND Clearance for Chronic Hepatitis B Following Earlier Fast Track and Orphan Drug Designations
SINGAPORE and GUANGZHOU, China, Sept. 15, 2025 /PRNewswire/ -- Lion TCR, a clinical-stage biotechnology company pioneering T-cell receptor (TCR)-based therapies, today announced that it has received Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA) to initi...
EverBridge Group and Cosmotec Forge Landmark Partnership
SHANGHAI, Sept. 15, 2025 /PRNewswire/ -- EverBridge Group announced an
Exclusive Commercialization Partnership with Cosmotec Inc. (a Wholly Owned
Subsidiary of M3, Inc.; TSE: 2413) for the Japanese market.
Real-World Evidence of NEFECON® to Be Presented in Seven New Abstracts at the 18th International lgAN Symposium
* 7 new NEFECON® real-world evidence abstracts will be presented at the 18th International lgA Nephropathy Symposium (IIgANN 2025). * The newly released results, based on clinical practices at several leading hospitals inChina, offer a comprehensive overview of the efficacy and safety of NEFE...
Senna Wellness Retreat introduces art showcase 'Trăng Lên Đỉnh Núi': A mid-autumn tribute to Kinh Bắc's beauty and community spirit
BAC NINH, Vietnam, Sept. 13, 2025 /PRNewswire/ -- From 12 to 21 September 2025, Senna Wellness Retreat presents the art showcase 'Trăng Lên Đỉnh Núi' to embrace its Mid-Autumn campaign's message of festive togetherness. Set against the breathtaking backdrop ofNorthern Vietnam, the showcase invite...
/C O R R E C T I O N -- Mars/
In the news release, Mars Snacking and Unreasonable Group Welcome Fourteen New Ventures to Unreasonable Food™, issued11-Sep-2025 by Mars over PR Newswire, we are advised by the company that the release has been updated to include the full 2025 Unreasonable Food cohort. The complete, corrected rel...
WFH mobilizes global community to achieve milestone revisions to WHO EML
MONTREAL, Sept. 12, 2025 /PRNewswire/ -- A concerted effort by the World Federation of Hemophilia (WFH) and its partners has led to the World Health Organization (WHO) updating its Essential Medicines List (EML) and the Essential Medicines List for Children (EMLc) to better align the EMLs to the ...
LakeShore Biopharma Announces Receipt of Delisting Determination Letter from Nasdaq
BEIJING, Sept. 12, 2025 /PRNewswire/ -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious ...
Pulnovo Medical Receives two IDE approvals for PADN system's clinical trials with CMS coverage
SHANGHAI, Sept. 12, 2025 /PRNewswire/ -- Pulnovo Medical, a globally recognized leader in medical devices for pulmonary hypertension (PH) and heart failure (HF), is proud to announce that its PADN catheter and generator has receivedtwo Investigational Device Exemption (IDE) approvals—HDE study ap...
3Shape Announces Leadership Transition: Rune Fisker Appointed External Executive Advisor to CEO After 25 Years of Pioneering Innovation
COPENHAGEN, Denmark, Sept. 12, 2025 /PRNewswire/ -- 3Shape today announced a leadership transition that honors one of its most influential innovators. After 25 years at the forefront of 3Shape's journey, Rune Fisker, Senior Vice President of Product Strategy, will step down from his current role ...
Week's Top Stories
Most Reposted
Amorepacific Showcases Innovative Technologies at CES 2026
[Picked up by 291 media titles]
2026-01-05 12:14Radisson Hotel Group Revives Bangkok Icon with Opening of Radisson Hotel Chateau de Bangkok
[Picked up by 283 media titles]
2026-01-06 10:45Panduit Announces Key Executive Appointments to Support Strategic Growth and Innovation
[Picked up by 281 media titles]
2026-01-07 10:00iQIYI LAND Yangzhou to Open on February 8, Marking New Chapter in China's Immersive Entertainment Scene
[Picked up by 280 media titles]
2026-01-01 10:00Space Summit 2026 to Convene Global Leaders in Singapore to Address the Growing Space Economy
[Picked up by 271 media titles]
2026-01-07 15:27